These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32924723)

  • 1. An appraisal of pivotal evaluation designs in validating noninvasive biomarkers for head and neck cancer detection.
    Adeoye J; Wan CCJ; Thomson P
    Acta Oncol; 2020 Dec; 59(12):1500-1502. PubMed ID: 32924723
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance spectroscopy of head and neck neoplasms.
    Shah GV; Gandhi D; Mukherji SK
    Top Magn Reson Imaging; 2004 Apr; 15(2):87-94. PubMed ID: 15269611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ⅰ. Current and Future Biomarkers Based on Conventional and Multiplexed Immunohistochemistry in Head and Neck Cancer].
    Tsujikawa T; Mitsuda J; Yoshimura K; Ohmura G; Arai A; Hirano S
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):889-893. PubMed ID: 34267023
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection, prediction, and prognosis: blood circulating microRNA as novel molecular markers of head and neck cancer patients.
    Powrózek T; Porgador A; Małecka-Massalska T
    Expert Rev Mol Diagn; 2020 Jan; 20(1):31-39. PubMed ID: 31778325
    [No Abstract]   [Full Text] [Related]  

  • 5. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.
    Lim Y; Sun CX; Tran P; Punyadeera C
    Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of genetic markers in the clinical care of patients with head and neck cancer.
    Friedlander PL
    Arch Otolaryngol Head Neck Surg; 2003 Mar; 129(3):363-6. PubMed ID: 12622551
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-free nucleic acids in body fluids as biomarkers for the prediction and early detection of recurrent head and neck cancer: A systematic review of the literature.
    van Ginkel JH; Slieker FJB; de Bree R; van Es RJJ; Van Cann EM; Willems SM
    Oral Oncol; 2017 Dec; 75():8-15. PubMed ID: 29224828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic markers in the clinical care of head and neck cancer: slow in coming.
    Koch W
    Arch Otolaryngol Head Neck Surg; 2003 Mar; 129(3):367-8. PubMed ID: 12622553
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic markers of head and neck cancer: identifying new molecular targets.
    Bradford CR
    Arch Otolaryngol Head Neck Surg; 2003 Mar; 129(3):366-7. PubMed ID: 12622552
    [No Abstract]   [Full Text] [Related]  

  • 10. Salivary protein biomarkers for head and neck cancer.
    Amenábar JM; Da Silva BM; Punyadeera C
    Expert Rev Mol Diagn; 2020 Mar; 20(3):305-313. PubMed ID: 31986927
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical implications of biomarkers in head and neck cancer.
    Koch WM
    Curr Oncol Rep; 1999; 1(2):129-37. PubMed ID: 11122809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein biomarker discovery for head and neck cancer.
    Schaaij-Visser TB; Brakenhoff RH; Leemans CR; Heck AJ; Slijper M
    J Proteomics; 2010 Sep; 73(10):1790-803. PubMed ID: 20139037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of serum biomarkers for head and neck cancer: A systematic review and meta-analysis.
    Guerra EN; Rêgo DF; Elias ST; Coletta RD; Mezzomo LA; Gozal D; De Luca Canto G
    Crit Rev Oncol Hematol; 2016 May; 101():93-118. PubMed ID: 26971993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
    BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum tumor markers of head and neck cancer: current status.
    Hanna EY; Papay FA; Gupta MK; Lavertu P; Tucker HM
    Head Neck; 1990; 12(1):50-9. PubMed ID: 2404906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2010 Multidisciplinary Head and Neck Cancer Symposium.
    Huang SH; O'Sullivan B
    Expert Rev Anticancer Ther; 2010 May; 10(5):651-3. PubMed ID: 20469996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mock clinical testing in the validation of fluid-phase biomarkers for head and neck carcinoma diagnosis: Scoping review.
    Adeoye J; Wan CCJ; Thomson P
    Head Neck; 2021 Feb; 43(2):691-704. PubMed ID: 33151603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of head and neck tumor markers].
    Gascón Vilaplana P
    Med Clin (Barc); 2007 Dec; 129(20):775-6. PubMed ID: 18093479
    [No Abstract]   [Full Text] [Related]  

  • 19. [Crystallization test in patients with head and neck neoplasms].
    Kuczkowski J; Zaorski P; Betlejewski A
    Otolaryngol Pol; 1995; 49 Suppl 20():121-4. PubMed ID: 9454116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of human papilloma virus DNA and expression of p53 protein in patients with head and neck cancer].
    Takano I; Tamura S; Yamanaka N
    Nihon Jibiinkoka Gakkai Kaiho; 1997 May; 100(5):524-33. PubMed ID: 9184031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.